Form 4: MapLight Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Christopher A. Kroeger, Chief Executive Officer and a Director of MapLight Therapeutics, Inc., sold 147,639 shares of common stock on July 15, 2026.
Summary
- Open-market sale: disposed of 18,950 Voting Common Stock at $36.00 ($682,200) on July 15, 2026; holds 1,375,144 after (Direct).
- Open-market sale: disposed of 42,738 Voting Common Stock at $36.99 ($1,580,879) on July 15, 2026; holds 1,332,406 after (Direct).
- Open-market sale: disposed of 90 Voting Common Stock at $37.54 ($3,379) on July 15, 2026; holds 1,332,316 after (Direct).
- Open-market sale: disposed of 40,899 Voting Common Stock at $36.46 ($1,491,178) on July 16, 2026; holds 1,291,417 after (Direct).
- Open-market sale: disposed of 28,091 Voting Common Stock at $37.26 ($1,046,671) on July 16, 2026; holds 1,263,326 after (Direct).
- Open-market sale: disposed of 92 Voting Common Stock at $37.96 ($3,492) on July 16, 2026; holds 1,263,234 after (Direct).
- Open-market sale: disposed of 16,779 Voting Common Stock at $37.90 ($635,924) on July 17, 2026; holds 1,246,455 after (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $5,443,722 of stock on the open market.
Insider Transactions
Christopher A. Kroeger — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market sale | Voting Common Stock | 18,950 | $36 | $682.2K | 1,375,144 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 42,738 | $37 | $1.6M | 1,332,406 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 90 | $38 | $3.4K | 1,332,316 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 40,899 | $36 | $1.5M | 1,291,417 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 28,091 | $37 | $1.0M | 1,263,326 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 92 | $38 | $3.5K | 1,263,234 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 16,779 | $38 | $635.9K | 1,246,455 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market sale (18,950 shares) |
| 2026-07-15 | Open-market sale (42,738 shares) |
| 2026-07-15 | Open-market sale (90 shares) |
| 2026-07-16 | Open-market sale (40,899 shares) |
| 2026-07-16 | Open-market sale (28,091 shares) |
| 2026-07-16 | Open-market sale (92 shares) |
| 2026-07-17 | Open-market sale (16,779 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Christopher A. Kroeger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.